FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Wutzler

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Geographic Areas

Germany

Anatomy

Cell Line

Co-author Network

Publications

TOP 3
Ralf Duerrwald; Michael Schlegel; Théophile Vissiennon; Peter Wutzler; Katja Bauer; Michaela Schmidtke
Efficacy of influenza vaccination and tamiflu® treatment - comparative studies with eurasian Swine influenza viruses in pigs.
Anja Philipps; Matthias Platzer; Horst Schirrmeier; Peter Wutzler; Malte Dauber; Marco Groth; Andi Krumbholz; Roland Zell
Isolation and molecular characterization of a second serotype of the encephalomyocarditis virus.
Andreas Sauerbrei; Roland Zell; Kathrin Bohn; Jan Simon Gronowitz; Andreas Henke; Kristin Liermann; Peter Wutzler
Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Wutzler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ralf Duerrwald; Michael Schlegel; Théophile Vissiennon; Peter Wutzler; Katja Bauer; Michaela Schmidtke
Efficacy of influenza vaccination and tamiflu® treatment - comparative studies with eurasian Swine influenza viruses in pigs.
PloS one 2013;8(4):e61597.
2012: Anja Philipps; Matthias Platzer; Horst Schirrmeier; Peter Wutzler; Malte Dauber; Marco Groth; Andi Krumbholz; Roland Zell
Isolation and molecular characterization of a second serotype of the encephalomyocarditis virus.
Veterinary microbiology 2012;161(1-2):49-57.
2012: Andreas Sauerbrei; Roland Zell; Kathrin Bohn; Jan Simon Gronowitz; Andreas Henke; Kristin Liermann; Peter Wutzler
Significance of amino acid substitutions in the thymidine kinase gene of herpes simplex virus type 1 for resistance.
Antiviral research 2012;96(2):105-7.
2012: Andreas Sauerbrei; M Schacke; Anna Schäfler; Bernd Gruhn; Jörg Hofmann; Peter Wutzler
Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.
Clinical and vaccine immunology : CVI 2012;19(8):1261-8.
2012: Undine Ott; Andreas Sauerbrei; Anna Schäfler; Mario Walther; Gunter Wolf; Peter Wutzler; Roland Zell; Jeannette Lange; Andi Krumbholz
Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
Medical microbiology and immunology 2012;201(3):297-302.
2012: Andi Krumbholz; Jeannette Lange; Ulrich Mohn; Manfred Motz; Eberhard Straube; Mario Walther; Jürgen J Wenzel; Peter Wutzler; Wolfgang Jilg; Roland Zell
Prevalence of hepatitis E virus-specific antibodies in humans with occupational exposure to pigs.
Medical microbiology and immunology 2012;201(2):239-44.
2012: Andreas Sauerbrei; Florian Pfaff; Roland Zell; Peter Wutzler
Prevalence of herpes simplex virus type 1 glycoprotein G (gG) and gI genotypes in patients with different herpetic diseases during the last four decades.
Journal of medical virology 2012;84(4):651-6.
2012: Katharina Sobotta; Nadine Wiesener; Steffi Wilsky; Peter Wutzler; Nadine Althof; Andreas Henke
Inhibition of nuclear factor kappa B activation reduces Coxsackievirus B3 replication in lymphoid cells.
Virus research 2012;163(2):495-502.
2012: Roland Zell; Florian Pfaff; Matthias Platzer; Stefan Taudien; Peter Wutzler; Andreas Sauerbrei
Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination.
Journal of virology 2012;86(3):1608-22.
2012: Steffi Wilsky; Peter Wutzler; Nadine Althof; Thomas Munder; Johanna Pilas; Katharina Sobotta; Nadine Wiesener; Andreas Henke
Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication.
Archives of virology 2012;157(2):259-69.
2012: Andreas Sauerbrei; M Schacke; Uwe Bust; Brigitte Glück; Holger F Rabenau; Peter Wutzler
Does limited virucidal activity of biocides include duck hepatitis B virucidal action?
BMC infectious diseases 2012;12():276.
2011: Timo Vesikari; Peter Wutzler; Frank Baehner; Astrid Borkowski; Aino Karvonen; Dorothee Kieninger-Baum; Markus Knuf; Heinz-Josef Schmitt; Theodore F Tsai; Ralf Clemens
Oil-in-water emulsion adjuvant with influenza vaccine in young children.
The New England journal of medicine 2011;365(15):1406-16.
2011: Thomas Weinke; Barbara Gärtner; Markus Knuf; Petra Sandow; Peter Wutzler
[Consensus report. Recommendations for the upcoming influenza vaccination season].
MMW Fortschritte der Medizin 2011;153(37):46-7.
2011: Nadine Wiesener; Peter Wutzler; Nadine Jarasch-Althof; Sara Lapp; Melissa Lehmann; Tatjana Schütze; Andreas Henke
Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
Viral immunology 2011;24(4):321-30.
2011: Andreas Sauerbrei; Johanna Taut; Roland Zell; Peter Wutzler
Resistance testing of clinical varicella-zoster virus strains.
Antiviral research 2011;90(3):242-7.
2011: Andreas Sauerbrei; J Stefanski; B Gruhn; Peter Wutzler
Immune response of varicella vaccinees to different varicella-zoster virus genotypes.
Vaccine 2011;29(22):3873-7.
2011: Nadine Wiesener; Christin Zimmer; Nadine Jarasch-Althof; Peter Wutzler; Andreas Henke
Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate.
Medical microbiology and immunology 2011;200(2):115-26.
2011: Andreas Sauerbrei; J Stefanski; A Philipps; Andi Krumbholz; Roland Zell; Peter Wutzler
Monitoring prevalence of varicella-zoster virus clades in Germany.
Medical microbiology and immunology 2011;200(2):99-107.
2011: Andi Krumbholz; Anja Philipps; Hartmut Oehring; Katja Schwarzer; Annett Eitner; Peter Wutzler; Roland Zell
Current knowledge on PB1-F2 of influenza A viruses.
Medical microbiology and immunology 2011;200(2):69-75.
2011: Andreas Sauerbrei; Nadine Wiesener; Roland Zell; Peter Wutzler
Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5.
Archives of virology 2011;156(3):505-9.
2011: Andreas Sauerbrei; Paul Schnitzler; Benedikt Weissbrich; Peter Wutzler; Roland Zell; Albert Heim; Dieter Hoffmann; Jörg Hofmann; Gerhard Jahn; Kathrin Bohn; Klaus Hamprecht
Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Antiviral therapy 2011;16(8):1297-308.
2011: Kathrin Bohn; M Schacke; Peter Wutzler; Roland Zell; Andreas Sauerbrei
Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus.
Antiviral therapy 2011;16(7):989-97.
2011: Eugene Muratov; Ekaterina V Varlamova; Anatoly G Artemenko; Tat'yana Khristova; Victor E Kuz'min; Vadim A Makarov; Olga B Riabova; Peter Wutzler; Michaela Schmidtke
QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.
Future medicinal chemistry 2011;3(1):15-27.
2010: Brigitte Glück; Katja Dahlke; Roland Zell; Andi Krumbholz; Michael Decker; Jochen Lehmann; Peter Wutzler
Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
Journal of medical virology 2010;82(12):2043-52.
2010: Andreas Sauerbrei; Stefanie Deinhardt; Roland Zell; Peter Wutzler
Testing of herpes simplex virus for resistance to antiviral drugs.
Virulence 2010;1(6):555-7.
2010: Andi Krumbholz; Tim Sandhaus; Angela Göhlert; Albert Heim; Roland Zell; Renate Egerer; Martin Breuer; Eberhard Straube; Peter Wutzler; Andreas Sauerbrei
Epstein-Barr virus-associated pneumonia and bronchiolitis obliterans syndrome in a lung transplant recipient.
Medical microbiology and immunology 2010;199(4):317-22.
2010: Ivanka Stankova; Kiril Chuchkov; Peter Wutzler; Michaela Schmidtke
Cinnamic esters of acyclovir-synthesis and biological activity.
Nucleosides, nucleotides & nucleic acids 2010;29(10):760-7.
2010: Andi Krumbholz; Jeannette Lange; Ralf Dürrwald; Heike Hoyer; Stefan Bengsch; Peter Wutzler; Roland Zell
Prevalence of antibodies to swine influenza viruses in humans with occupational exposure to pigs, Thuringia, Germany, 2008-2009.
Journal of medical virology 2010;82(9):1617-25.
2010: Nadine Jarasch-Althof; Nadine Wiesener; Michaela Schmidtke; Peter Wutzler; Andreas Henke
Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
Viral immunology 2010;23(4):369-76.
2010: Ulrich Lotze; Renate Egerer; Brigitte Glück; Roland Zell; Holger Sigusch; Christian Erhardt; Albert Heim; Reinhard Kandolf; Thomas Bock; Peter Wutzler; Hans R Figulla
Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.
Journal of medical virology 2010;82(8):1449-57.
2010: Andreas Sauerbrei; Peter Wutzler
Virucidal efficacy of povidone-iodine-containing disinfectants.
Letters in applied microbiology 2010;51(2):158-63.
2010: Eugene Muratov; Anatoly G Artemenko; Ekaterina V Varlamova; Pavel G Polischuk; Victor P Lozitsky; Alla S Fedchuk; Regina L Lozitska; Tat'yana L Gridina; Ludmila S Koroleva; Vladimir N Sil'nikov; Angel S Galabov; Vadim A Makarov; Olga B Riabova; Peter Wutzler; Michaela Schmidtke; Victor E Kuz'min
Per aspera ad astra: application of Simplex QSAR approach in antiviral research.
Future medicinal chemistry 2010;2(7):1205-26.
2010: Ralf Dürrwald; Andi Krumbholz; Sigrid Baumgarte; Michael Schlegel; Thomas W Vahlenkamp; Hans-Joachim Selbitz; Peter Wutzler; Roland Zell
Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity.
Emerging infectious diseases 2010;16(6):1029-30.
2010: Andreas Sauerbrei; S Deinhardt; Roland Zell; Peter Wutzler
Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
Antiviral research 2010;86(3):246-52.
2010: Peter Wutzler
[Zoster vaccine].
Klinische Monatsblätter für Augenheilkunde 2010;227(5):384-7.
2010: Ulrike Grienke; Michaela Schmidtke; Johannes Kirchmair; Kathrin Pfarr; Peter Wutzler; Ralf Dürrwald; Gerhard Wolber; Klaus Liedl; Hermann Stuppner; Judith M Rollinger
Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai.
Journal of medicinal chemistry 2010;53(2):778-86.
2009: Andreas Sauerbrei; K Bohn; Roland Zell; Peter Wutzler
Variability of immediate-early gene 62 in german varicella-zoster virus wild-type strains.
Journal of clinical microbiology 2009;47(11):3717-20.
2009: Peter Wutzler; Ruprecht Schmidt-Ott; Heike Hoyer; Andreas Sauerbrei
Prevalence of influenza A and B antibodies in pregnant women and their offspring.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;46(2):161-4.
2009: Niklas Finnström; Karin Bergsten; Helena Ström; Therese Sundell; Sophie Martin; Peter Wutzler; Andreas Sauerbrei
Analysis of varicella-zoster virus and herpes simplex virus in various clinical samples by the use of different PCR assays.
Journal of virological methods 2009;160(1-2):193-6.
2009: Andi Krumbholz; Olaf Bininda-Emonds; Peter Wutzler; Roland Zell
Phylogenetics, evolution, and medical importance of polyomaviruses.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2009;9(5):784-99.
2009: Andreas Sauerbrei; R Schmidt-Ott; Heike Hoyer; Peter Wutzler
Seroprevalence of influenza A and B in German infants and adolescents.
Medical microbiology and immunology 2009;198(2):93-101.
2009: Katja Bauer; Martina Richter; Peter Wutzler; Michaela Schmidtke
Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
Antiviral research 2009;82(1):34-41.
2009: Peter Wutzler
[Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
Deutsche medizinische Wochenschrift (1946) 2009;134 Suppl 2():S90-4.
2009: Andi Krumbholz; Michaela Schmidtke; Silke Bergmann; Susann Motzke; Katja Bauer; Jürgen Stech; Ralf Dürrwald; Peter Wutzler; Roland Zell
High prevalence of amantadine resistance among circulating European porcine influenza A viruses.
The Journal of general virology 2009;90(Pt 4):900-8.
2009: M Schacke; Brigitte Glück; Peter Wutzler; Andreas Sauerbrei
In vitro cultivation and cryopreservation of duck embryonic hepatocytes.
Journal of virological methods 2009;157(1):25-31.
2009: Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Varicella vaccination in Europe - taking the practical approach.
BMC medicine 2009;7():26.
2009: Andreas Sauerbrei; Peter Wutzler
Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Clinical laboratory 2009;55(1-2):1-7.
2009: Andreas Sauerbrei; Peter Wutzler
Testing thermal resistance of viruses.
Archives of virology 2009;154(1):115-9.
2008: Roland Zell; Yvonne Ihle; Madlen Effenberger; Simone Seitz; Peter Wutzler; Matthias Görlach
Interaction of poly(rC)-binding protein 2 domains KH1 and KH3 with coxsackievirus RNA.
Biochemical and biophysical research communications 2008;377(2):500-3.
2008: Andreas Henke; Nadine Jarasch; Peter Wutzler
Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis.
Expert review of vaccines 2008;7(10):1557-67.
2008: Roland Zell; Andi Krumbholz; Peter Wutzler
Impact of global warming on viral diseases: what is the evidence?
Current opinion in biotechnology 2008;19(6):652-60.
2008: Andi Krumbholz; Olaf Bininda-Emonds; Peter Wutzler; Roland Zell
Evolution of four BK virus subtypes.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2008;8(5):632-43.
2008: Peter Wutzler; Markus Knuf; Johannes Liese
Varicella: efficacy of two-dose vaccination in childhood.
Deutsches Ärzteblatt international 2008;105(33):567-72.
2008: Michaela Schmidtke; Katja Bauer; Nicole Ludwig; Peter Wutzler
Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
International journal of antimicrobial agents 2008;32(2):192-5.
2008: Andreas Sauerbrei; Roland Zell; A Philipps; Peter Wutzler
Genotypes of varicella-zoster virus wild-type strains in Germany.
Journal of medical virology 2008;80(6):1123-30.
2008: Catherine Sadzot; Bernard Rentier; Peter Wutzler; Yoshizo Asano; Sadao Suga; Tetsushi Yoshikawa; Stanley A Plotkin
Varicella vaccination in Japan, South Korea, and Europe.
The Journal of infectious diseases 2008;197 Suppl 2():S185-90.
2008: Andreas Henke; Nadine Jarasch; Ulrike Martin; Roland Zell; Peter Wutzler
Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma.
Viral immunology 2008;21(1):38-48.
2008: Astrid Meerbach; Peter Wutzler; Ralf Häfer; Felix Zintl; Bernd Gruhn
Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Journal of medical virology 2008;80(3):441-54.
2008: Judith M Rollinger; Theodora M Steindl; Daniela Schuster; Johannes Kirchmair; Kathrin Anrain; Ernst P Ellmerer; Thierry Langer; Hermann Stuppner; Peter Wutzler; Michaela Schmidtke
Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein.
Journal of medicinal chemistry 2008;51(4):842-51.
2008: Roland Zell; Yvonne Ihle; Simone Seitz; Ulrike Gündel; Peter Wutzler; Matthias Görlach
Poly(rC)-binding protein 2 interacts with the oligo(rC) tract of coxsackievirus B3.
Biochemical and biophysical research communications 2008;366(4):917-21.
2008: Andi Krumbholz; Peter Wutzler; Roland Zell
The non-coding region of BK subtype II viruses.
Virus genes 2008;36(1):27-9.
2008: Roland Zell; Silke Bergmann; Andi Krumbholz; Peter Wutzler; Ralf Dürrwald
Ongoing evolution of swine influenza viruses: a novel reassortant.
Archives of virology 2008;153(11):2085-92.
2008: Roland Zell; Susann Motzke; Andi Krumbholz; Peter Wutzler; Volker Herwig; Ralf Dürrwald
Novel reassortant of swine influenza H1N2 virus in Germany.
The Journal of general virology 2008;89(Pt 1):271-6.
2008: Andreas Henke; Nadine Jarasch; Ulrike Martin; Jenny Wegert; Anja Wildner; Roland Zell; Peter Wutzler
Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
International journal of medical microbiology : IJMM 2008;298(1-2):127-34.
2007: Thomas Hammerschmidt; Helmtrud Bisanz; Peter Wutzler
Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis.
Vaccine 2007;25(42):7307-12.
2007: Andreas Sauerbrei; Anja Philipps; Roland Zell; Peter Wutzler
Genotyping of varicella-zoster virus strains after serial passages in cell culture.
Journal of virological methods 2007;145(1):80-3.
2007: Michaela Schmidtke; Ingrid Merkle; K Klingel; Elke Hammerschmidt; Andreas Zautner; Peter Wutzler
The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Journal of medical virology 2007;79(9):1334-42.
2007: Andreas Sauerbrei; Peter Wutzler
Novel recombinant ELISA assays for determination of type-specific IgG antibodies against HSV-1 and HSV-2.
Journal of virological methods 2007;144(1-2):138-42.
2007: Nadine Jarasch; Ulrike Martin; Roland Zell; Peter Wutzler; Andreas Henke
Influence of pan-caspase inhibitors on coxsackievirus B3-infected CD19+ B lymphocytes.
Apoptosis : an international journal on programmed cell death 2007;12(9):1633-43.
2007: Katja Bauer; Christina Schrader; Jochen Suess; Peter Wutzler; Michaela Schmidtke
Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.
Antiviral research 2007;75(3):219-26.
2007: Victor E Kuz'min; Anatoly G Artemenko; Eugene Muratov; Ingrid L Volineckaya; Vadim A Makarov; Olga B Riabova; Peter Wutzler; Michaela Schmidtke
Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication.
Journal of medicinal chemistry 2007;50(17):4205-13.
2007: Anatoly G Artemenko; Eugene Muratov; Victor E Kuz'min; N A Kovdienko; A I Hromov; Vadim A Makarov; Olga B Riabova; Peter Wutzler; Michaela Schmidtke
Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds.
The Journal of antimicrobial chemotherapy 2007;60(1):68-77.
2007: Andreas Sauerbrei; Peter Wutzler
Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
Journal of medical virology 2007;79(7):1025-31.
2007: Andreas Sauerbrei; Peter Wutzler
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections.
Medical microbiology and immunology 2007;196(2):95-102.
2007: Andreas Sauerbrei; Peter Wutzler
Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: herpes simplex virus infections.
Medical microbiology and immunology 2007;196(2):89-94.
2007: Samuel Aballéa; Jeremy V M Chancellor; Monique Martin; Peter Wutzler; Fabrice CARRAT; Roberto Gasparini; Joao Toniolo-Neto; Michael Drummond; Milton Weinstein
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10(2):98-116.
2007: Andreas Sauerbrei; Ulrich Eichhorn; M Scheibenzuber; Peter Wutzler
Hexon denaturation of human adenoviruses by different groups of biocides.
The Journal of hospital infection 2007;65(3):264-70.
2007: Ulrike Martin; Nadine Jarasch; Matthias Nestler; Alexander Rassmann; Thomas Munder; Simone Seitz; Roland Zell; Peter Wutzler; Andreas Henke
Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3.
Apoptosis : an international journal on programmed cell death 2007;12(3):525-33.
2007: Roland Zell; Andi Krumbholz; Annett Eitner; Reimar Krieg; Karl-Jürgen Halbhuber; Peter Wutzler
Prevalence of PB1-F2 of influenza A viruses.
The Journal of general virology 2007;88(Pt 2):536-46.
2007: Peter Wutzler; Andreas Sauerbrei
[Varicella during pregnancy and in neonates].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2007;50(2):237-44.
2007: Andreas Sauerbrei; Roland Zell; Peter Wutzler
Analysis of repeat units in the R2 region among different Oka varicella-zoster virus vaccine strains and wild-type strains in Germany.
Intervirology 2007;50(1):40-4.
2006: Andi Krumbholz; Roland Zell; Renate Egerer; Andreas Sauerbrei; Andrea Helming; Bernd Gruhn; Peter Wutzler
Prevalence of BK virus subtype I in Germany.
Journal of medical virology 2006;78(12):1588-98.
2006: Andreas Sauerbrei; M Schacke; Brigitte Glück; Renate Egerer; Peter Wutzler
Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus.
The Journal of hospital infection 2006;64(4):358-65.
2006: Roland Zell; Andi Krumbholz; Peter Wutzler
Influenza A virus PB1-F2 gene.
Emerging infectious diseases 2006;12(10):1607-8; author reply 1608-9.
2006: Andreas Sauerbrei; Roland Zell; M Harder; Peter Wutzler
Genotyping of different varicella vaccine strains.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;37(2):109-17.
2006: Andreas Sauerbrei; Peter Wutzler
Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
Journal of clinical microbiology 2006;44(9):3094-7.
2006: Markus Knuf; A Neiss; Peter Wutzler
[Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].
Klinische Pädiatrie 2006;218(4):203-12.
2006: Andreas Zautner; Birgit Jahn; Elke Hammerschmidt; Peter Wutzler; Michaela Schmidtke
N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells.
Journal of virology 2006;80(13):6629-36.
2006: Astrid Meerbach; Andreas Sauerbrei; Werner Meerbach; Hans-Jörg Bittrich; Peter Wutzler
Fatal outcome of herpes simplex virus type 1-induced necrotic hepatitis in a neonate.
Medical microbiology and immunology 2006;195(2):101-5.
2006: Andreas Sauerbrei; A Haertl; A Brandstaedt; Michaela Schmidtke; Peter Wutzler
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
Medical microbiology and immunology 2006;195(2):65-71.
2006: Astrid Meerbach; Chris Meier; Andreas Sauerbrei; Heide-Marie Meckel; Peter Wutzler
Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
International journal of antimicrobial agents 2006;27(5):423-30.
2006: Andi Krumbholz; Astrid Meerbach; Roland Zell; Bernd Gruhn; Andreas Henke; Eckhard Birch-Hirschfeld; Peter Wutzler
Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR.
Journal of medical virology 2006;78(5):598-607.
2006: Peter Wutzler
[Prophylactic influenza vaccination: what is the situation in Germany?].
Deutsche medizinische Wochenschrift (1946) 2006;131(9):453-7.
2006: Roland Zell; Andi Krumbholz; Malte Dauber; Elizabeth Hoey; Peter Wutzler
Molecular-based reclassification of the bovine enteroviruses.
The Journal of general virology 2006;87(Pt 2):375-85.
2006: Michaela Schmidtke; Roland Zell; Katja Bauer; Andi Krumbholz; Christina Schrader; Jochen Suess; Peter Wutzler
Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001.
Intervirology 2006;49(5):286-93.
2006: Andreas Henke; Nadine Rohland; Roland Zell; Peter Wutzler
Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections.
Intervirology 2006;49(4):249-52.
2006: Andreas Sauerbrei; Chris Meier; Astrid Meerbach; Peter Wutzler
Inhibitory efficacy of cyclosal-nucleoside monophosphates of aciclovir and brivudin on DNA synthesis of orthopoxvi ruses.
Antiviral chemistry & chemotherapy 2006;17(1):25-31.
2005: Andreas Sauerbrei; M Schacke; U Schultz; Renate Egerer; Ingrid Merkle; D Glebe; Wolfram H Gerlich; Peter Wutzler
Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Journal of virological methods 2005;129(2):178-85.
2005: Roland Zell; Simone Seitz; Andreas Henke; Thomas Munder; Peter Wutzler
Linkage map of protein-protein interactions of Porcine teschovirus.
The Journal of general virology 2005;86(Pt 10):2763-8.
2005: Michaela Schmidtke; Elke Hammerschmidt; Susanne Schüler; Roland Zell; Eckhard Birch-Hirschfeld; Vadim A Makarov; Olga B Riabova; Peter Wutzler
Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
The Journal of antimicrobial chemotherapy 2005;56(4):648-56.
2005: Andreas Sauerbrei; Chris Meier; Astrid Meerbach; M Schiel; B Helbig; Peter Wutzler
In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
Antiviral research 2005;67(3):147-54.
2005: Vadim A Makarov; Olga B Riabova; Vladimir G Granik; Peter Wutzler; Michaela Schmidtke
Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
The Journal of antimicrobial chemotherapy 2005;55(4):483-8.
2005: Daniela Müller; Peter Wutzler; Thomas D Szucs
Influenza vaccination coverage rates in Germany a population-based cross-sectional analysis of the seasons 2002/2003 and 2003/2004.
Medizinische Klinik (Munich, Germany : 1983) 2005;100(1):6-13.
2005: Vadim A Makarov; Olga B Riabova; Vladimir G Granik; Hans-Martin Dahse; Axel Stelzner; Peter Wutzler; Michaela Schmidtke
Anti-coxsackievirus B3 activity of 2-amino-3-nitropyrazolo[1,5-a]pyrimidines and their analogs.
Bioorganic & medicinal chemistry letters 2005;15(1):37-9.
2005: Nadine Jarasch; Ulrike Martin; Esther Kamphausen; Roland Zell; Peter Wutzler; Andreas Henke
Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.
Viral immunology 2005;18(2):355-64.
2004: Andreas Sauerbrei; Elena Rubtcova; Peter Wutzler; D Scott Schmid; Vladimir N Loparev
Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Journal of clinical microbiology 2004;42(12):5604-8.
2004: Stefan Wagenpfeil; Albrecht Neiss; Peter Wutzler
Effects of varicella vaccination on herpes zoster incidence.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(11):954-60.
2004: Peter Wutzler; K-D Kossow; Hartmut Lode; B R Ruf; H Scholz; G E Vogel
Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(2):84-91.
2004: Andreas Sauerbrei; Peter Wutzler
[Varicella during pregnancy. 2. Diagnosis, prevention and therapy].
Deutsche medizinische Wochenschrift (1946) 2004;129(39):2045-7.
2004: Andreas Sauerbrei; Peter Wutzler
[Varicella during pregnancy. 1: Epidemiology and clinical aspects].
Deutsche medizinische Wochenschrift (1946) 2004;129(38):1983-6.
2004: Andreas Sauerbrei; I Färber; Antje Brandstädt; M Schacke; Peter Wutzler
Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
Journal of virological methods 2004;119(1):25-30.
2004: Astrid Meerbach; Claudia Friedrichs; Rudolf Thust; Peter Wutzler
Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Archives of virology 2004;149(6):1083-94.
2004: Claudia Friedrichs; Johan Neyts; Gabor Gaspar; Erik De Clercq; Peter Wutzler
Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.
Antiviral research 2004;62(3):121-3.
2004: Andreas Sauerbrei; K Sehr; Ulrich Eichhorn; Karen Reimer; Peter Wutzler
Inactivation of human adenovirus genome by different groups of disinfectants.
The Journal of hospital infection 2004;57(1):67-72.
2004: Andreas Sauerbrei; K Sehr; Antje Brandstädt; Albert Heim; Karen Reimer; Peter Wutzler
Sensitivity of human adenoviruses to different groups of chemical biocides.
The Journal of hospital infection 2004;57(1):59-66.
2004: Stefan Wagenpfeil; Albrecht Neiss; Kurt Banz; Peter Wutzler
Empirical data on the varicella situation in Germany for vaccination decisions.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(5):425-30.
2004: Astrid Meerbach; Bernd Gruhn; Peter Wutzler
Recent developments in the prevention and treatment of Epstein-Barr virus-associated lymphoproliferative diseases.
Expert opinion on therapeutic patents 2004;14(4):527-47.
2004: Kurt Banz; Stefan Wagenpfeil; Albrecht Neiss; Thomas Hammerschmidt; Peter Wutzler
The burden of varicella in Germany. Potential risks and economic impact.
The European journal of health economics : HEPAC : health economics in prevention and care 2004;5(1):46-53.
2004: Andreas Sauerbrei; Peter Wutzler
Serological detection of type-specific IgG to herpes simplex virus by novel ELISAs based on recombinant and highly purified glycoprotein G.
Clinical laboratory 2004;50(7-8):425-9.
2004: Peter Wutzler; Andreas Sauerbrei
Virucidal activity of the new disinfectant monopercitric acid.
Letters in applied microbiology 2004;39(2):194-8.
2004: Zeno Foeldes-Papp; Renate Egerer; Eckhard Birch-Hirschfeld; Hans-Martin Striebel; Ulrike Demel; Gernot P Tilz; Peter Wutzler
Detection of multiple human herpes viruses by DNA microarray technology.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology 2004;8(1):1-9.
2004: Andreas Sauerbrei; J Prager; A Bischoff; Peter Wutzler
[Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Diphtheria, pertussis, tetanus].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2004;47(1):16-20.
2004: Andreas Sauerbrei; J Prager; A Bischoff; Peter Wutzler
[Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Measles, mumps, rubella, poliomyelitis, and varicella].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2004;47(1):10-5.
2004: Albert Härtl; Andreas Sauerbrei; Axel Stelzner; Peter Wutzler
Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds.
Arzneimittel-Forschung 2004;54(2):130-4.
2004: Thomas Hammerschmidt; Kurt Banz; Stefan Wagenpfeil; Albrecht Neiss; Peter Wutzler
Economic evaluation of varicella vaccination programmes: a review of the literature.
PharmacoEconomics 2004;22(2):133-6; author reply136-8.
2004: Rudolf Thust; Maja T Tomicic; Rolf Gräbner; Claudia Friedrichs; Peter Wutzler; Bernd Kaina
Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells.
Mutagenesis 2004;19(1):27-33.
2003: Andreas Henke; Nadine Jarasch; Peter Wutzler
Vaccination procedures against Coxsackievirus-induced heart disease.
Expert review of vaccines 2003;2(6):805-15.
2003: Andreas Sauerbrei; J Pawlak; C Luger; Peter Wutzler
Intracerebral varicella-zoster virus reactivation in congenital varicella syndrome.
Developmental medicine and child neurology 2003;45(12):837-40.
2003: Andi Krumbholz; Rüdiger Wurm; Oliver Scheck; Eckhard Birch-Hirschfeld; Renate Egerer; Andreas Henke; Peter Wutzler; Roland Zell
Detection of porcine teschoviruses and enteroviruses by LightCycler real-time PCR.
Journal of virological methods 2003;113(1):51-63.
2003: Andreas Sauerbrei; Ulrich Eichhorn; S Gawellek; Renate Egerer; M Schacke; Peter Wutzler
Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Journal of medical virology 2003;71(2):313-9.
2003: Thomas Hammerschmidt; Anita Goertz; Stefan Wagenpfeil; Albrecht Neiss; Peter Wutzler; Kurt Banz
Validation of health economic models: the example of EVITA.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2003;6(5):551-9.
2003: Peter Hyckel; Peter Schleier; Astrid Meerbach; Alexander Berndt; Hartwig Kosmehl; Peter Wutzler
The therapy of virus-associated epithelial tumors of the face and the lips in organ transplant recipients.
Medical microbiology and immunology 2003;192(3):171-6.
2003: Andreas Sauerbrei; B Uebe; Peter Wutzler
Molecular diagnosis of zoster post varicella vaccination.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;27(2):190-9.
2003: Sawko W Wassilew; Peter Wutzler
Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia.
Antiviral research 2003;59(1):57-60.
2003: Sawko W Wassilew; Peter Wutzler
Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study.
Antiviral research 2003;59(1):49-56.
2003: Bernd Gruhn; Astrid Meerbach; Ralf Häfer; Roland Zell; Peter Wutzler; Felix Zintl
Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(11):1023-5.
2003: Andreas Sauerbrei; Johannes Pawlak; Christoph Luger; Peter Wutzler
Hints of intracerebral varicella-zoster virus reactivation in congenital varicella syndrome.
European journal of pediatrics 2003;162(5):354-5.
2003: Kurt Banz; Stefan Wagenpfeil; Albrecht Neiss; Anita Goertz; U Staginnus; J Vollmar; Peter Wutzler
The cost-effectiveness of routine childhood varicella vaccination in Germany.
Vaccine 2003;21(11-12):1256-67.
2003: Andreas Sauerbrei; A Ulbricht; Peter Wutzler
Semi-quantitative detection of viral RNA in influenza A virus-infected mice for evaluation of antiviral compounds.
Antiviral research 2003;58(1):81-7.
2003: Maja T Tomicic; Claudia Friedrichs; Markus Christmann; Peter Wutzler; Rudolf Thust; Bernd Kaina
Apoptosis induced by (E)-5-(2-bromovinyl)-2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8.
Molecular pharmacology 2003;63(2):439-49.
2003: M Schacke; Astrid Meerbach; Rudolf Thust; Peter Hyckel; Peter Wutzler
Establishment and cidofovir sensitivity of a cell line from a heart transplant recipient with multiple cutaneous tumors.
Neoplasma 2003;50(3):165-71.
2003: Peter Wutzler; Andreas Sauerbrei; Albert Härtl; Karen Reimer
Comparative testing of liposomal and aqueous formulations of povidone-iodine for their angioirritative potential at the chorioallantoic membrane of ex ovo cultivated chick embryos.
Dermatology (Basel, Switzerland) 2003;207(1):43-7.
2002: Peter Wutzler
[New diagnostic possibilities and medications. Fit for influenza?].
MMW Fortschritte der Medizin 2002;144(48):18.
2002: Chris Meier; Andreas Lomp; Astrid Meerbach; Peter Wutzler
CycloSal-BVDUMP pronucleotides: how to convert an antiviral-inactive nucleoside analogue into a bioactive compound against EBV.
Journal of medicinal chemistry 2002;45(23):5157-72.
2002: Peter Wutzler; Albrecht Neiss; Kurt Banz; Anita Goertz; Helmtrud Bisanz
Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Medical microbiology and immunology 2002;191(2):89-96.
2002: Maja T Tomicic; Erato Bey; Peter Wutzler; Rudolf Thust; Bernd Kaina
Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir.
Mutation research 2002;505(1-2):1-11.
2002: R Klöcking; B Helbig; G Schötz; M Schacke; Peter Wutzler
Anti-HSV-1 activity of synthetic humic acid-like polymers derived from p-diphenolic starting compounds.
Antiviral chemistry & chemotherapy 2002;13(4):241-9.
2002: Andreas Sauerbrei; Peter Wutzler
Laboratory diagnosis of central nervous system infections caused by herpesviruses.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;25 Suppl 1():S45-51.
2002: Peter Wutzler; Andreas Sauerbrei; R Klöcking; B Brögmann; Karen Reimer
Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine.
Antiviral research 2002;54(2):89-97.
2002: Andreas Sauerbrei; Manfred Sommer; Ulrich Eichhorn; Peter Wutzler
[Laboratory diagnosis of herpes zoster: virology or serology?].
Medizinische Klinik (Munich, Germany : 1983) 2002;97(3):123-7.
2002: Andreas Sauerbrei; Annemarie Groh; A Bischoff; J Prager; Peter Wutzler
Antibodies against vaccine-preventable diseases in pregnant women and their offspring in the eastern part of Germany.
Medical microbiology and immunology 2002;190(4):167-72.
2002: Andreas Sauerbrei; Peter Wutzler
Placental boost to varicella-zoster antibodies in the newborn.
Journal of perinatal medicine 2002;30(4):345-8.
2002: Karen Reimer; Thomas A Wichelhaus; Volker Schäfer; P Rudolph; A Kramer; Peter Wutzler; D Ganzer; W Fleischer
Antimicrobial effectiveness of povidone-iodine and consequences for new application areas.
Dermatology (Basel, Switzerland) 2002;204 Suppl 1():114-20.
2001: Andreas Sauerbrei; Peter Wutzler
Neonatal varicella.
Journal of perinatology : official journal of the California Perinatal Association 2001;21(8):545-9.
2001: Astrid Meerbach; Johan Neyts; J Balzarini; B Helbig; Erik De Clercq; Peter Wutzler
In vitro activity of polyhydroxycarboxylates against herpesviruses and HIV.
Antiviral chemistry & chemotherapy 2001;12(6):337-45.
2001: Peter Wutzler; I Färber; S Wagenpfeil; Helmtrud Bisanz; A Tischer
Seroprevalence of varicella-zoster virus in the German population.
Vaccine 2001;20(1-2):121-4.
2001: Astrid Meerbach; Bernd Gruhn; Renate Egerer; U Reischl; Felix Zintl; Peter Wutzler
Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases.
Journal of medical virology 2001;65(2):348-57.
2001: Chris Meier; Andreas Lomp; Astrid Meerbach; Peter Wutzler
cycloSaligenyl-5-[(E)-2-bromovinyl]-2'-deoxyuridine monophosphate (cycloSal-BVDUMP) pronucleotides active against Epstein-Barr virus.
Chembiochem : a European journal of chemical biology 2001;2(4):283-5.
2001: Chris Meier; Andreas Lomp; Astrid Meerbach; Peter Wutzler
Synthesis, hydrolysis and anti-EBV activity of a series of 3'-modified cycloSal-BVDUMP pronucleotides.
Nucleosides, nucleotides & nucleic acids 2001;20(4-7):307-14.
2001: I Färber; W Hinderer; M Rothe; D Lang; HH Sonneborn; Peter Wutzler
Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
Journal of medical virology 2001;63(4):271-6.
2001: Peter Hyckel; Alexander Berndt; Peter Wutzler; Hartwig Kosmehl
[Tumors of the face in organ transplant patients].
Mund-, Kiefer- und Gesichtschirurgie : MKG 2001;5(2):94-7.
2001: Peter Wutzler; Rudolf Thust
Genetic risks of antiviral nucleoside analogues--a survey.
Antiviral research 2001;49(2):55-74.
2000: Andreas Sauerbrei; Peter Wutzler
The congenital varicella syndrome.
Journal of perinatology : official journal of the California Perinatal Association 2000;20(8 Pt 1):548-54.
2000: Peter Wutzler; Andreas Sauerbrei
Virucidal efficacy of a combination of 0.2% peracetic acid and 80% (v/v) ethanol (PAA-ethanol) as a potential hand disinfectant.
The Journal of hospital infection 2000;46(4):304-8.
2000: Andreas Sauerbrei; Brigitte Glück; K Jung; H Bittrich; Peter Wutzler
Congenital skin lesions caused by intrauterine infection with coxsackievirus B3.
Infection 2000;28(5):326-8.
2000: Andreas Sauerbrei; Ulrich Eichhorn; G Hottenrott; Peter Wutzler
Virological diagnosis of herpes simplex encephalitis.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2000;17(1):31-6.
2000: Peter Wutzler; H W Doerr; I Färber; Ulrich Eichhorn; B Helbig; Andreas Sauerbrei; Antje Brandstädt; H F Rabenau
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes.
Journal of medical virology 2000;61(2):201-7.
2000: Peter Wutzler; Andreas Sauerbrei; R Klöcking; J Burkhardt; M Schacke; Rudolf Thust; W Fleischer; Karen Reimer
Virucidal and chlamydicidal activities of eye drops with povidone-iodine liposome complex.
Ophthalmic research 2000;32(2-3):118-25.
2000: Rudolf Thust; Maja T Tomicic; R Klöcking; Peter Wutzler; Bernd Kaina
Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir.
Mutagenesis 2000;15(2):177-84.
2000: Peter Wutzler
[Neuraminidase inhibitor for treatment of influenza A and B].
Der Internist 2000;41(2 Pt 2):223-9.
2000: Astrid Meerbach; R Klöcking; Chris Meier; Andreas Lomp; B Helbig; Peter Wutzler
Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV.
Antiviral research 2000;45(1):69-77.
2000: Rudolf Thust; Maja T Tomicic; R Klöcking; N Voutilainen; Peter Wutzler; Bernd Kaina
Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: implications for gene therapeutic approaches.
Cancer gene therapy 2000;7(1):107-17.
1999: Andreas Sauerbrei; Manfred Sommer; Peter Wutzler
[Virologic diagnosis of herpes zoster].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 1999;50(12):873-8.
1999: Andreas Sauerbrei; Ulrich Eichhorn; M Schacke; Peter Wutzler
Laboratory diagnosis of herpes zoster.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 1999;14(1):31-6.
1999: Andreas Lomp; Chris Meier; Markus Herderich; Peter Wutzler
Evidence for cyclophosphate formation during hydrolysis of 3-methyl-cycloSal-PCVMP.
Nucleosides & nucleotides 1999;18(4-5):943-4.
1999: Peter Wutzler; Andreas Sauerbrei
Infections during pregnancy.
Contributions to microbiology 1999;3():141-9.
1998: Chris Meier; L Habel; F Haller-Meier; Andreas Lomp; Markus Herderich; R Klöcking; Astrid Meerbach; Peter Wutzler
Chemistry and anti-herpes simplex virus type 1 evaluation of cycloSal-nucleotides of acyclic nucleoside analogues.
Antiviral chemistry & chemotherapy 1998;9(5):389-402.
1998: Astrid Meerbach; A Holý; Peter Wutzler; Erik De Clercq; Johan Neyts
Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication.
Antiviral chemistry & chemotherapy 1998;9(3):275-82.
1997: Andreas Sauerbrei; J Prager; Ulf Hengst; Felix Zintl; Peter Wutzler
Varicella vaccination in children after bone marrow transplantation.
Bone marrow transplantation 1997;20(5):381-3.
1997: Peter Wutzler; A Ulbricht; I Färber
Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice.
Intervirology 1997;40(1):15-21.
1996: Andreas Sauerbrei; D Müller; U Eichhorn; Peter Wutzler
Detection of varicella-zoster virus in congenital varicella syndrome: a case report.
Obstetrics and gynecology 1996;88(4 Pt 2):687-9.
1996: R Thust; M Schacke; Peter Wutzler
Cytogenetic genotoxicity of antiherpes virostatics in Chinese hamster V79-E cells. I. Purine nucleoside analogues.
Antiviral research 1996;31(1-2):105-13.
1995: Peter Wutzler; E De Clercq; K Wutke; I Färber
Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial.
Journal of medical virology 1995;46(3):252-7.
1995: Peter Wutzler; Astrid Meerbach; I Färber; H Wolf; K Scheibner
Malignant lymphomas induced by an Epstein-Barr virus-related herpesvirus from Macaca arctoides--a rabbit model.
Archives of virology 1995;140(11):1979-95.
1993: H Mücke; K T Mohr; A Rümmler; Peter Wutzler
[Skin pH value on hands after application of soap, cleaners and hand disinfectants].
Die Pharmazie 1993;48(6):468-9.
1993: I Färber; Peter Wutzler; P Wohlrabe; H Wolf; W Hinderer; HH Sonneborn
Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs.
Journal of virological methods 1993;42(2-3):301-7.
1992: S Ludwig; U Ludwig; I Färber; Peter Wutzler; E Straube; H Koch; J Hermann; D Fuchs; Felix Zintl
[Infections after bone marrow transplantation in childhood].
Kinderärztliche Praxis 1992;60(4-5):119-23.
1992: B Paul; W Pfister; Peter Wutzler; P Gängler
[Individual plaque flora determination in periodontal diseases. Methods and standardization].
Deutsche Zahn-, Mund-, und Kieferheilkunde mit Zentralblatt 1992;80(1):7-12.
1992: Andreas Sauerbrei; Peter Wutzler
[Varicella zoster virus infections in pregnancy].
Zentralblatt für Gynäkologie 1992;114(5):259-64.
1991: I Färber; Peter Wutzler
FC receptors induced by human herpesvirus-6.
Acta virologica 1991;35(4):400.
1991: C Lindemann; W Pfister; Peter Wutzler; P Gängler
[Microbiological parameters in periodontitis marginalis during local treatment].
Deutsche Stomatologie (Berlin, Germany : 1990) 1991;41(1):30-4.
1990: Andreas Sauerbrei; I Färber; Peter Wutzler; R Swoboda; J Schneider
[Detection of Epstein-Barr virus in the tonsils in infectious mononucleosis].
Laryngo- rhino- otologie 1990;69(2):70-3.
1990: Andreas Sauerbrei; Peter Wutzler; W Pfister; U Kaiser; D Schreiber; K D Rüdiger
[Microbiological and morphological findings in reactive lymphadenopathy].
Zentralblatt für allgemeine Pathologie und pathologische Anatomie 1990;136(5):419-25.
1990: Andreas Sauerbrei; S Sonntag; Peter Wutzler
[Prevalence of varicella zoster virus in pregnant patients].
Zentralblatt für Gynäkologie 1990;112(4):223-6.
1990: J Martin; W Nowak; K D Thiel; Peter Wutzler; U Kraft
[Biocompatibility of various surgical drainage materials in the cytotoxicity and implantation test].
Zeitschrift für experimentelle Chirurgie, Transplantation, und künstliche Organe : Organ der Sektion Experimentelle Chirurgie der Gesellschaft für Chirurgie der DDR 1990;23(4):205-8.
1989: P Wohlrabe; I Färber; Peter Wutzler; R Uhlig
Antibodies to Epstein-Barr virus-induced early antigens in blood donors.
Acta virologica 1989;33(4):344-8.
1989: H Mücke; Peter Wutzler; S Recknagel
[Odorless surface disinfection with peracetic acid].
Zeitschrift für ärztliche Fortbildung 1989;83(22):1125-7.
1989: W Pfister; Peter Wutzler; K Hesse
[Haemophilus actinomycetemcomitans as a cause of infection in medicine and stomatology].
Zeitschrift für ärztliche Fortbildung 1989;83(12):609-12.
1989: Felix Zintl; I Färber; J Hermann; D Fuchs; J Prager; Peter Wutzler
CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
Folia haematologica (Leipzig, Germany : 1928) 1989;116(3-4):557-64.
1988: Peter Wutzler; K Wutke; D Bärwolff; J Reefschläger
[5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1988;43(23):677-80.
1988: Peter Wutzler; B Helbig; A Ulbricht; Astrid Meerbach; W Pradel
Therapeutic effect of pyrophosphate analogues on cutaneous herpes simplex virus type 1 infection in guinea pigs.
Antiviral research 1988;10(1-3):99-106.
1988: H Töpke; M Gräf; Peter Wutzler; G Herrmann; J Reefschläger
Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
Antiviral research 1988;9(4):273-80.
1988: R Beer; Peter Wutzler; P Gängler; W Pfister
[Comparative biological and microbiological testing of root canal filling materials].
Zahn-, Mund-, und Kieferheilkunde mit Zentralblatt 1988;76(5):473-81.
1987: B Helbig; Andreas Sauerbrei; R Klöcking; Peter Wutzler; N Wicht; U Wiedemann; G Herrmann
Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs.
Journal of medical virology 1987;23(3):303-9.
1987: Peter Wutzler; K D Thiel; M Tonew; E Tonew; H P Schröer; Axel Stelzner
[Biological effects of coordinated compounds of transitional metals. 7. Antiviral activity of 4-methyl-2-aminopyridine palladium chloride against herpes simplex virus type 1 and type 2 in vitro and in vivo].
Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1987;266(3-4):563-6.
1987: J Reefschläger; Peter Wutzler; K D Thiel; G Herrmann
Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
Pharmaceutical research 1987;4(3):200-6.
1987: J Reefschläger; Peter Wutzler; K D Thiel; H Töpke; D Bärwolff; P Langen
[(E)-5-(2-bromovinyl)-2'-desoxyuridine--a new nucleoside analog with selective inhibitory action against herpesviruses. Studies in cell culture and animal experiments].
Die Pharmazie 1987;42(6):407-11.
1987: Peter Wutzler; H Mücke; H Battke; P Goebel; D Schreiber
[Animal experiment studies of the effect of peracetic acid on bladder urothelium].
Zeitschrift für Urologie und Nephrologie 1987;80(2):105-10.
1987: W Pfister; Peter Wutzler; P Gängler; C Lindemann
[Plaque microflora of healthy gingiva as well as gingivitis and marginal periodontitis].
Zahn-, Mund-, und Kieferheilkunde mit Zentralblatt 1987;75(8):804-8.
1987: W Pfister; P Kleinert; H C Sandig; Peter Wutzler; A Ruschitschka; U Schäfer
[Adhesive properties of dental materials studied by using radioactively labelled bacteria].
Zahn-, Mund-, und Kieferheilkunde mit Zentralblatt 1987;75(5):456-8.
1987: I Färber; C Klinger; Peter Wutzler; K D Thiel; J Reefschläger; G Herrmann
Effect of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil on Epstein-Barr virus antigen expression in P3HR-1 cells: comparison with acyclovir.
Acta virologica 1987;31(1):13-8.
1987: Andreas Sauerbrei; Peter Wutzler; I Färber; K Wutke; B Brichacek; I Hirsch
[Detection of Epstein-Barr virus nucleic acid sequences in non-Hodgkin's lymphoma].
Archiv für Geschwulstforschung 1987;57(6):445-52.
1986: I Färber; G Sauerbrei; Peter Wutzler; G Weinmann
[Herpesvirus infections in children with acute lymphatic leukemia].
Klinische Pädiatrie 1986;198(6):471-5.
1986: Andreas Sauerbrei; Peter Wutzler; I Färber; B Brichácek; R Swoboda; S Macheleidt
Comparative detection of herpesviruses in tissue specimens by in situ hybridization and immunofluorescence.
Acta virologica 1986;30(3):213-9.
1986: K D Thiel; Peter Wutzler; K Issleib; W Mögelin; A Balszuweit
[Antiviral activity of new pyrophosphate analog compounds].
Die Pharmazie 1986;41(4):295-6.
1986: J Reefschläger; Peter Wutzler; K D Thiel; G Herrmann
Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
Antiviral research 1986;6(2):83-93.
1986: Peter Wutzler; I Färber; Andreas Sauerbrei; B Helbig; K Wutke; K D Rüdiger; K Scheibner; B Brichàcek; V Vonka
Demonstration of Epstein-Barr virus in malignant non-Hodgkin's lymphomas.
Oncology 1986;43(4):224-9.
1985: A Ulbricht; I Färber; Peter Wutzler
Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
Acta virologica 1985;29(6):493-8.
1985: Peter Wutzler; Andreas Sauerbrei; M Sprössig; J Hadlich; A Ulbricht; K D Thiel
[Clinical and virological studies of eczema herpeticum].
Dermatologische Monatschrift 1985;171(4):222-9.
1984: K D Thiel; Peter Wutzler; B Helbig; R Klöcking; M Sprössig; H Schweizer
[Antiviral effect of enzymatically and nonenzymatically oxidized caffeic and hydrocaffeic acids against Herpesvirus hominis type 1 and type 2 in vitro].
Die Pharmazie 1984;39(11):781-2.
1984: P Wohlrabe; M Sprössig; I Färber; Peter Wutzler; D Steube; D Schreiber
[Virologico-serologic studies in patients with brain tumors].
Zentralblatt für Neurochirurgie 1984;45(2):152-8.
1983: Andreas Sauerbrei; Peter Wutzler; M Sprössig
[Excretion of herpes simplex virus in the oropharynx. Clinical importance and epidemiological significance].
MMW, Münchener medizinische Wochenschrift 1983;125(23):495-7.
1983: K D Thiel; B Helbig; M Sprössig; R Klöcking; Peter Wutzler
Antiviral activity of enzymatically oxidized caffeic acid against herpesvirus hominis type 1 and type 2.
Acta virologica 1983;27(3):200-8.
1983: Andreas Sauerbrei; M Sprössig; Peter Wutzler; I Färber; H Schweizer; R Swoboda; J Wilke
[Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
Laryngologie, Rhinologie, Otologie 1983;62(4):170-4.
1983: Peter Wutzler; I Färber; M Sprössig; Andreas Sauerbrei; K Wutke; D Höche; K D Rüdiger; W Wöckel; K Scheibner
Antibodies against herpesviruses in patients with Hodgkin's disease.
Archiv für Geschwulstforschung 1983;53(5):417-22.
1982: H Schweizer; M Sprössig; Peter Wutzler; K D Thiel
[Procedure for the fast testing of serum for its usefulness in cell culturing].
Zeitschrift für die gesamte Hygiene und ihre Grenzgebiete 1982;28(11):775-7.
1982: J Reefschläger; Peter Wutzler; K D Thiel; D Bärwolff; P Langen; M Sprössig; H A Rosenthal
Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice.
Antiviral research 1982;2(5):255-65.
1982: K D Thiel; Peter Wutzler; M Sprössig; D Bertram
[Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
Die Pharmazie 1982;37(8):608.
1982: W Koall; E Mampel; G Schneider; R Schulze; I Färber; Peter Wutzler
[Cytomegalovirus infections following kidney transplantation - clinical and serological studies of the early and late phases].
Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete 1982;37(8):236-42.
1982: K D Thiel; Peter Wutzler; H Schweizer
[Use of the rabbit testicular cells in the plaque assay for herpesvirus hominis type 1 and 2].
Acta microbiologica Academiae Scientiarum Hungaricae 1982;29(1):67-8.
1982: W Wöckel; K D Rüdiger; K Wutke; J Wilke; Peter Wutzler; M Sprössig; J Hirsch; B Brichaćek; V Vonka
[Contribution to the true non-African Burkitt's lymphoma (author's transl)].
Zentralblatt für allgemeine Pathologie und pathologische Anatomie 1982;126(1-2):113-22.
1981: Peter Wutzler; Andreas Sauerbrei; H Schweizer; K D Thiel
[Production of hyper-immune serum for diagnosis of herpes virus hominis infections].
Zeitschrift für die gesamte Hygiene und ihre Grenzgebiete 1981;27(8):620-3.
1981: K D Thiel; B Helbig; R Klöcking; Peter Wutzler; M Sprössig; H Schweizer
[Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus (author's transl)].
Die Pharmazie 1981;36(1):50-3.
1980: Peter Wutzler; M Sprössig; J Hirsch; B Brichaćek; V Vonka; E Schindler; K Wutke; K D Rüdiger; W Wöckel
[Demonstration of Epstein-Barr virus genome in european Burkitt lymphoma (author's transl)].
Deutsche medizinische Wochenschrift (1946) 1980;105(27):961-6.
1980: Peter Wutzler; Andreas Sauerbrei; M Sprössig; I Färber; H Schweizer
Diagnosis of Herpesvirus hominis infections with the use of Ehrlich mouse ascites tumour cells.
Acta virologica 1980;24(2):132-6.